Reckitt Benckiser LLC v. Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (D. Del.).
Timothy Kratz and George Barry represent Aurobindo in this patent case involving Aurobindo’s application to market generic versions of Mucinex® DM. In March 2017, the trial court granted Aurobindo’s motion for summary judgment of non-infringement, an extraordinary outcome for ANDA litigation generally, and in particular in a jurisdiction where summary judgment motion in pharmaceutical patent litigation cases are disfavored.